Kennedy Capital Management’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,106
Closed -$53.6K 695
2024
Q1
$53.6K Sell
10,106
-53,118
-84% -$303K ﹤0.01% 722
2023
Q4
$395K Buy
+63,224
New +$262K 0.01% 643
2023
Q3
Sell
-12,179
Closed -$72.9K 674
2023
Q2
$72.9K Hold
12,179
﹤0.01% 663
2023
Q1
$90.8K Hold
12,179
﹤0.01% 610
2022
Q4
$151K Sell
12,179
-2
-0% -$35 ﹤0.01% 601
2022
Q3
$251K Buy
12,181
+5,258
+76% +$146K 0.01% 587
2022
Q2
$192K Sell
6,923
-66
-0.9% -$2.26K 0.01% 589
2022
Q1
$305K Sell
6,989
-1,078
-13% -$46.9K 0.01% 576
2021
Q4
$445K Buy
+8,067
New +$498K 0.01% 571
2018
Q2
Sell
-74,078
Closed -$1.37M 728
2018
Q1
$1.37M Buy
+74,078
New +$1.4M 0.03% 642

Other funds holding AFMD

Kennedy Capital Management's AFMD Position: Q2 2024 in Review

Kennedy Capital Management sold out of Affimed (AFMD) in Q2 2024, closing a stake of 10,106 shares — an estimated $53.6K sold.

Kennedy Capital Management first reported a position in AFMD in Q1 2018 and held it in 10 quarters. The position peaked at $1.37M in Q1 2018. 44 funds tracked by Wall St. Rank hold AFMD as of Q2 2024.

  • Kennedy Capital Management reported no remaining Affimed position as of Q2 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 10,106 Affimed shares in Q2 2024, an estimated $53.6K.
  • Kennedy Capital Management first reported a position in Affimed in Q1 2018 and held it in 10 quarters.
  • Kennedy Capital Management's Affimed position peaked at $1.37M in Q1 2018.
  • 44 funds tracked by Wall St. Rank held Affimed as of Q2 2024.

Based on Kennedy Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.